GLP1 medications have been shown to reduce the risk of diabetes in higher-risk individuals by 93%, so this is all relative7
Consequently, it has been shown to ameliorate experimental colitis in several animal models (9396) and a GLP-2 analog was proven effective in the treatment of active moderate to severe CD (97)
Medical Disclaimer Prescription & FDA Status: All treatments, including BPC-157, TB-500, Semaglutide, and Tirzepatide, require a medical consultation and are issued at the providers discretion
Las estrategias naturales para apoyar la salud metablica pueden complementar, pero no necesariamente reemplazar, el tratamiento mdico cuando est indicado
the MannWhitney U test for independent samples and the Wilcoxon signed rank test for paired samples